Investigation of the Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block in Management of Postoperative Pain After Septoplasty
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 主要终点
- total amount of tramadol consumption
研究概览
简要总结
The aim of this clinical study will investigate the efficacy of sphenopalatine ganglion block in the treatment of postoperative pain.it will also be learnt whether it reduces the consumption of analgesics in postoperative pain.The main questions it aims to answer are:
Will the participants' need for painkillers decrease after the operation? Can sphenopalatine ganglion block be used for postoperative pain after septoplasty? The researchers will compare 2 groups with and without sphenopalatine ganglion block to see the effectiveness of sphenopalatine ganglion block.
Participants will:
Read the information Participants have been given about the sphenopalatine ganglion block.
In case of any side effects, please contact participant's doctor.
详细描述
This randomised controlled study will be conducted in Umraniye Training and Research Hospital operating room between November 2024 and January 2025 after obtaining ethics committee and patient consent. Each patient will be informed about the procedures to be performed during anaesthesia and surgery and signed informed consent will be obtained before the procedure. Patients will undergo septoplasty by the same otolaryngology team.
A total of 50 participants (25 envelopes each with Group 1 and Group 2 written inside) will be kept closed for the patients participating in the study. Upon the patient's fulfilment of the conditions suitable for the study, it will be randomly determined which group he/she will be included in. Thanks to this randomisation, conscious or unconscious manipulations in the selection of patients to the study group will be prevented.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participants who will undergo septoplasty
- •18 to 50 years old
- •ASA score 1 or 2
排除标准
- •Under 18 or over 50 years of age
- •ASA score III and above patient group
- •The patient is allergic to any of the drugs used
- •The patient has a contraindication to any of the drugs used
- •Use of anticoagulant medication
- •Failure of the patient to give consent
- •Being pregnant
- •Those with GCS retardation such as dementia, mental retardation
- •Those with diagnosed headache
结局指标
主要结局
total amount of tramadol consumption
时间窗: 24 hours
Total tramadol consumption will be recorded in the postoperative period by fitting participants with a patient-controlled analgesia device.
visual analogue scale
时间窗: 24 hours
Zero is equivalent to no pain and 10 indicates the worst possible pain.
次要结局
未报告次要终点
研究者
Senay Goksu
specialist doctor
Umraniye Education and Research Hospital